Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review
Book Details
Author(s)GlobalData
PublisherMarketResearch.com
ISBN / ASINB004Z1ZYB0
ISBN-13978B004Z1ZYB7
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸
Description
Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review
Summary
Astellas Pharma Inc. (Astellas) is a global pharmaceutical company engaged in developing, manufacturing, marketing of pharmaceuticals and related products. The company’s principal business activity is manufacturing, marketing and import/export of pharmaceuticals. Astellas’s product portfolio is targeted against a wide range of diseases such as, immunology, infection, gastroenterology, oncology, immunology, pain, and diabetes among others. Additionally, Astellas has a broad pipeline of products under various stages of development such as phase I, II, II, and clinical and pre-clinical trials. It is focused on developing new drugs and supplying them to the patients in need. The company has vast research and development capabilities and efficient in-house sales force. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, and Philippines, among others. Astellas is headquartered in Chuo-Ku, Tokyo, Japan.
Astellas Pharma Inc. Key Recent DevelopmentsÂ…
Mar 24, 2011: Astellas European Foundation Pledges Support To Japan Earthquake Relief
Mar 16, 2011: OSI, Genentech, Pfizer And Teva Reach Settlement Agreement In Tarceva Patent Case
Mar 14, 2011: Astellas To Donate JPY100m For Earthquake Relief Efforts In Japan
Feb 15, 2011: Astellas Withdraws Application For Marketing Approval Of Darexaban In Japan
Jan 10, 2011: Astellas To Review Strategic Business Alternatives For Prosidion Subsidiary
This comprehensive SWOT profile of Astellas Pharma Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Summary
Astellas Pharma Inc. (Astellas) is a global pharmaceutical company engaged in developing, manufacturing, marketing of pharmaceuticals and related products. The company’s principal business activity is manufacturing, marketing and import/export of pharmaceuticals. Astellas’s product portfolio is targeted against a wide range of diseases such as, immunology, infection, gastroenterology, oncology, immunology, pain, and diabetes among others. Additionally, Astellas has a broad pipeline of products under various stages of development such as phase I, II, II, and clinical and pre-clinical trials. It is focused on developing new drugs and supplying them to the patients in need. The company has vast research and development capabilities and efficient in-house sales force. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, and Philippines, among others. Astellas is headquartered in Chuo-Ku, Tokyo, Japan.
Astellas Pharma Inc. Key Recent DevelopmentsÂ…
Mar 24, 2011: Astellas European Foundation Pledges Support To Japan Earthquake Relief
Mar 16, 2011: OSI, Genentech, Pfizer And Teva Reach Settlement Agreement In Tarceva Patent Case
Mar 14, 2011: Astellas To Donate JPY100m For Earthquake Relief Efforts In Japan
Feb 15, 2011: Astellas Withdraws Application For Marketing Approval Of Darexaban In Japan
Jan 10, 2011: Astellas To Review Strategic Business Alternatives For Prosidion Subsidiary
This comprehensive SWOT profile of Astellas Pharma Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

